LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 36,287 Value ($000) $50 Avg Close — Range —
Q2 2024
Shares 85,462 Value ($000) $124 Avg Close — Range —
Q1 2024
Shares 91,094 Value ($000) $203 Avg Close — Range —
Q4 2023
Shares 92,101 Value ($000) $179 Avg Close — Range —
Q3 2023
Shares 92,101 Value ($000) $135 Avg Close — Range —
Q2 2023
Shares 92,101 Value ($000) $293 Avg Close — Range —
Q1 2023
Shares 75,014 Value ($000) $177 Avg Close — Range —
Q4 2022
Shares 92,502 Value ($000) $321 Avg Close — Range —
Q3 2022
Shares 92,502 Value ($000) $678 Avg Close — Range —
Q2 2022
Shares 92,502 Value ($000) $603 Avg Close — Range —
Q1 2022
Shares 84,513 Value ($000) $427 Avg Close — Range —
Q3 2021
Shares 10,321 Value ($000) $153 Avg Close — Range —